Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Extracellular

biology, digitalisation and biomanufacturing to accelerate cultivated meat
2022
Nov-50
11-50
Bristol, Bristol, City of, United Kingdom

Innovation

Industry Problem

Cell-agriculture companies often lack the specialist infrastructure, process expertise and manufacturing capacity needed to move from laboratory work to commercial production.

R&D Focus

Cell-culture process development, scale-up and contract manufacturing for food and materials.

Innovative Solution

Operates as a CDMO providing cell-line and media development, process design, regulatory support, scale-up and kilogram-to-tonne manufacturing.

Investment Funding

Last Funding Stage

Non-equity Assistance

Total Funding Amount

2.42M

Last Funding Date

12-06-2024

Startup Stage

Seed

Lead Investors

Big Idea Ventures, MassChallenge, Future Food Fund, Unruly Capital, Good Startup

About

Extracellular channels biology, digitalisation and biomanufacturing expertise to accelerate developments in biotech. We use our scale up experience and our deep insights into cellular behaviour to produce biomass for cultivated meat companies more efficiently. We’re digitalising process development, pulling together huge quantities of data to make better decisions faster and at scale.

Products

Product

Cell-agriculture development, scale-up and contract-manufacturing services.

Star Product

End-to-end cell-agriculture CDMO platform – combines R&D, scale-up and manufacturing support.

Demo Product or Complete Product?

Commercial B2B development and manufacturing services.

Awards and Recognitions

Awards

FoodTech 500 (2025).

Certifications

Registered as a UK food business in 2026.

M&A and Collabs

Collab

Roslin Technologies and Nutreco – cell-agriculture and nutrition ecosystem collaborations.

Collab

Merck, University of Bristol and Rutgers University – technology and research collaborations listed by the company.

Something missing or incorrect on this page? Help us enrich this information